Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Nufarm (NUF.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (A$) Price Target (A$) Rating
2022-04-116.606.73Buy
2022-04-276.597.90Buy
2022-05-196.077.40Buy
2022-11-175.867.50Buy
2023-05-186.057.30Buy
2023-09-284.727.00Buy
2024-05-234.736.90Buy
2024-08-164.024.50Neutral
2025-05-222.63-No Rating

Disclosures

  • UBS Securities Australia Limited is advising Nufarm Limited on a strategic review of their business - Seed Technologies, and may receive a fee for acting in this capacity.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.